GB8730011D0
(en)
*
|
1987-12-23 |
1988-02-03 |
Smithkline Dauelsberg |
Pharmaceutical compositions
|
US5096716A
(en)
*
|
1988-09-01 |
1992-03-17 |
Alza Corporation |
Dosage form for administering calcium antagonist nicardipine
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
US5186942A
(en)
*
|
1989-01-30 |
1993-02-16 |
Alza Corporation |
Nicardipine therapy
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
DE4101873C2
(de)
*
|
1991-01-23 |
1993-12-09 |
Isis Pharma Gmbh |
Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
KR100212353B1
(ko)
*
|
1991-10-24 |
1999-08-02 |
하비 자콥스 |
하이드로겔 전기분해에 의해 생성된 기체압력을 이용한 약물주입 시스템
|
US5330762A
(en)
*
|
1992-02-27 |
1994-07-19 |
Alza Corporation |
Tandospiaine antidepressive therapy
|
US5185158A
(en)
*
|
1992-02-27 |
1993-02-09 |
Alza Corporation |
Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
|
US5246711A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating dysthymia
|
US5858407A
(en)
*
|
1992-02-27 |
1999-01-12 |
Alza Corporation |
Method for administering tandospirone
|
US5246710A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating cyclothymia
|
US5688518A
(en)
*
|
1992-02-27 |
1997-11-18 |
Alza Corporation |
Antidepressive therapy
|
US5462741A
(en)
*
|
1992-08-06 |
1995-10-31 |
Alza Corporation |
High agent loaded controlled release dispenser
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6919373B1
(en)
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
US6203813B1
(en)
|
1997-01-13 |
2001-03-20 |
Lance L. Gooberman |
Pharmaceutical delivery device and method of preparation therefor
|
US5951538A
(en)
*
|
1997-08-07 |
1999-09-14 |
Ceramatec, Inc. |
Gas generating device for delivering beneficial agents to a body cavity
|
US6645192B2
(en)
*
|
1998-09-30 |
2003-11-11 |
Ivy Animal Health, Inc. |
Pellet implant system for immediate and delayed release of antiparasitic drug
|
US6706282B1
(en)
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
IL142807A0
(en)
|
1998-11-02 |
2002-03-10 |
Alza Corp |
Controlled delivery of active agents
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
US6491683B1
(en)
|
1999-09-07 |
2002-12-10 |
Alza Corporation |
Osmotic dosage form composed of an extruded polymer tube form
|
ATE290365T1
(de)
*
|
1999-12-16 |
2005-03-15 |
Alza Corp |
Darreichungsformen mit einer sperrschicht gegen laserablation
|
US20040010000A1
(en)
*
|
2002-04-29 |
2004-01-15 |
Ayer Atul D. |
Methods and dosage forms for controlled delivery of oxycodone
|
JP2005528423A
(ja)
*
|
2002-05-31 |
2005-09-22 |
アルザ・コーポレーシヨン |
オキシコドンの変動性投薬用量の浸透圧的送達のための剤形および組成物
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
CA2494233A1
(en)
*
|
2002-07-29 |
2004-02-05 |
Alza Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
CA2512786A1
(en)
*
|
2003-01-14 |
2004-08-05 |
Alza Corporation |
Methods and dosage forms with modified viscosity layers
|
DE602004015246D1
(de)
*
|
2003-02-11 |
2008-09-04 |
Alza Corp |
Verfahren und dosierformen mit modifizierter schichtgeometrie
|
DE102004032051A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
DE10336400A1
(de)
*
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
EP1653922A2
(en)
*
|
2003-08-06 |
2006-05-10 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
US20070048228A1
(en)
*
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE102005005446A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
BRPI0413361B8
(pt)
*
|
2003-08-06 |
2021-05-25 |
Gruenenthal Gmbh |
comprimido seguro contra abuso termo-moldado por extrusão sem descoramento
|
US20050136108A1
(en)
*
|
2003-08-22 |
2005-06-23 |
Yam Noymi V. |
Stepwise delivery of topiramate over prolonged period of time
|
CA2540056C
(en)
*
|
2003-09-26 |
2015-03-24 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
MXPA06003450A
(es)
*
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Recubrimiento de farmaco que proporciona alta carga del farmaco y metodos para proporcionar el mismo.
|
KR20060095765A
(ko)
*
|
2003-09-26 |
2006-09-01 |
알자 코포레이션 |
알프라졸람의 제어 송달용 삼투성 제형
|
ATE504288T1
(de)
*
|
2003-09-26 |
2011-04-15 |
Alza Corp |
Oros-push-stick für die kontrollierte abgabe von wirkstoffen
|
AU2004308973A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Alza Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
AU2004312084A1
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc. |
Novel drug compositions and dosage forms of topiramate
|
MXPA06007509A
(es)
*
|
2003-12-29 |
2007-10-18 |
Johnson & Johnson |
Composiciones de farmaco y formas de dosis novedosas.
|
DE102004032103A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
DE102004032049A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
CA2577583A1
(en)
*
|
2004-08-19 |
2006-03-02 |
Alza Corporation |
Controlled release nanoparticle active agent formulation dosage forms and methods
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US7959938B2
(en)
*
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
US8778395B2
(en)
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
WO2007041079A2
(en)
*
|
2005-09-30 |
2007-04-12 |
Alza Corporation |
Banded controlled release nanoparticle active agent formulation dosage forms and methods
|
KR20130100029A
(ko)
*
|
2005-12-30 |
2013-09-06 |
모르 리서치 애플리케이션즈 리미티드 |
항문 괄약근을 치료하기 위한 장치
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US9011930B2
(en)
*
|
2006-05-01 |
2015-04-21 |
Zycal Bioceuticals Healthcare Company, Inc. |
Nutritional supplement and use thereof
|
DE602007009377D1
(de)
|
2006-05-30 |
2010-11-04 |
Intarcia Therapeutics Inc |
Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
|
US7682356B2
(en)
|
2006-08-09 |
2010-03-23 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies for use therein
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
US7538652B2
(en)
*
|
2006-08-29 |
2009-05-26 |
International Business Machines Corporation |
Electrical component tuned by conductive layer deletion
|
DE102007011485A1
(de)
*
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
JP5351884B2
(ja)
|
2007-04-23 |
2013-11-27 |
インターシア セラピューティクス,インコーポレイティド |
インスリン分泌促進性ペプチドの懸濁製剤及び使用
|
BRPI0906467C1
(pt)
*
|
2008-01-25 |
2021-05-25 |
Gruenenthal Gmbh |
forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
LT2273983T
(lt)
*
|
2008-05-09 |
2016-10-25 |
Grünenthal GmbH |
Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija
|
EP2445481B1
(en)
|
2009-06-18 |
2017-03-22 |
Rdd Pharma Ltd. |
Methods and devices for delivery of pharmaceutical agents within orifices of the body
|
AU2010275754B2
(en)
|
2009-07-22 |
2014-05-15 |
Grünenthal GmbH |
Tamper-resistant dosage form for oxidation-sensitive opioids
|
EP2456427B1
(en)
|
2009-07-22 |
2015-03-04 |
Grünenthal GmbH |
Hot-melt extruded controlled release dosage form
|
US9053844B2
(en)
*
|
2009-09-09 |
2015-06-09 |
Littelfuse, Inc. |
Geometric configuration or alignment of protective material in a gap structure for electrical devices
|
HUE035862T2
(en)
|
2009-09-28 |
2018-05-28 |
Intarcia Therapeutics Inc |
Rapid development and / or completion of substantially steady-state drug delivery
|
WO2011095314A2
(en)
*
|
2010-02-03 |
2011-08-11 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
MX2013002293A
(es)
|
2010-09-02 |
2013-05-09 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
|
WO2012028319A1
(en)
|
2010-09-02 |
2012-03-08 |
Grünenthal GmbH |
Tamper resistant dosage form comprising inorganic salt
|
WO2012050922A2
(en)
|
2010-09-28 |
2012-04-19 |
Depomed, Inc. |
Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
LT2736497T
(lt)
|
2011-07-29 |
2017-11-10 |
Grünenthal GmbH |
Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
|
BR112014002022A2
(pt)
|
2011-07-29 |
2017-02-21 |
Gruenenthal Gmbh |
comprimido resistente à violação proporcionando liberação de fármaco imediata
|
US20130225697A1
(en)
|
2012-02-28 |
2013-08-29 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
AU2013248351B2
(en)
|
2012-04-18 |
2018-04-26 |
Grunenthal Gmbh |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
US20140088345A1
(en)
*
|
2012-09-27 |
2014-03-27 |
Palo Alto Research Center Incorporated |
Single channel, multiple drug delivery device and methods
|
JP6466417B2
(ja)
|
2013-05-29 |
2019-02-06 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
二峰性放出プロファイルを有する改変防止(tamper−resistant)剤形
|
CA2907950A1
(en)
|
2013-05-29 |
2014-12-04 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing one or more particles
|
EA032465B1
(ru)
|
2013-07-12 |
2019-05-31 |
Грюненталь Гмбх |
Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления
|
AU2014356581C1
(en)
|
2013-11-26 |
2020-05-28 |
Grunenthal Gmbh |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
US20160310408A1
(en)
*
|
2013-12-06 |
2016-10-27 |
Durect Corporation |
Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
|
US9297083B2
(en)
|
2013-12-16 |
2016-03-29 |
Palo Alto Research Center Incorporated |
Electrolytic gas generating devices, actuators, and methods
|
CN106572980A
(zh)
|
2014-05-12 |
2017-04-19 |
格吕伦塔尔有限公司 |
包含他喷他多的防篡改即释胶囊制剂
|
CN106456550A
(zh)
|
2014-05-26 |
2017-02-22 |
格吕伦塔尔有限公司 |
避免乙醇剂量倾泻的多颗粒
|
US10278675B2
(en)
|
2014-07-31 |
2019-05-07 |
Palo Alto Research Center Incorporated |
Implantable estrus detection devices, systems, and methods
|
US9801660B2
(en)
|
2014-07-31 |
2017-10-31 |
Palo Alto Research Center Incorporated |
Implantable fluid delivery devices, systems, and methods
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
AU2016251854A1
(en)
|
2015-04-24 |
2017-10-19 |
Grunenthal Gmbh |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
ES2968262T3
(es)
|
2015-06-03 |
2024-05-08 |
I2O Therapeutics Inc |
Sistemas de colocación de implantes
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
WO2017200943A1
(en)
|
2016-05-16 |
2017-11-23 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
CN110225762A
(zh)
|
2017-01-03 |
2019-09-10 |
因塔西亚制药公司 |
包括glp-1受体激动剂的连续施用和药物的共同施用的方法
|
US9707217B1
(en)
|
2017-02-03 |
2017-07-18 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dose-dumping resistant controlled release dosage form
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
LT4037666T
(lt)
|
2020-12-08 |
2024-06-10 |
Ruminant Biotech Corp Limited |
Medžiagų pristatymo gyvūnams prietaisų ir būdų patobulinimai
|